PHASE 2 STUDY
Clinical trials for PHASE 2 STUDY explained in plain language.
Never miss a new study
Get alerted when new PHASE 2 STUDY trials appear
Sign up with your email to follow new studies for PHASE 2 STUDY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive lymphoma: targeted combo aims to keep cancer in check
Disease control Recruiting nowThis study tests whether giving the drug glofitamab after an initial treatment with BTKi and rituximab can better control high-risk mantle cell lymphoma (MCL) that has not been treated before. About 30 adults with newly diagnosed, high-risk MCL will receive this two-step approach…
Matched conditions: PHASE 2 STUDY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for pancreatic cancer: targeted drug combo enters phase 2 trial
Disease control Recruiting nowThis study tests whether adding the drug BMS-986504 to standard chemotherapy can help control pancreatic cancer in people whose tumors have a specific genetic change (MTAP deletion). About 60 adults with this cancer type will receive the combination either before/after surgery or…
Matched conditions: PHASE 2 STUDY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:29 UTC